Titlebook: Combined Modality Therapy of Gastrointestinal Tract Cancer; Peter Schlag,Peter Hohenberger,Urs Metzger Conference proceedings 1988 Springe

财主

Adjuvant Portal Infusion Chemotherapy in Colorectal Cancerors, the liver again is the most frequent site of relapse in 40%-50% [4, 18]. Once liver metastases have developed, the prognosis is poor, with an expected median survival of 6-9 months [2, 14], the extent of the tumor being the most important prognostic factor [22]. A great deal of work has been do

ticlopidine

CEDE

The Northwest of England Rectal Cancer Trialm of the anal verge. The prognosis following surgery in operable rectal cancer is 30% surviving at 5 years. A large proportion of patients die with evidence of recurrent rectal cancer in the pelvis. Local recurrence appears to be associated with invasion of tumor into surrounding structures which ar

潜伏期

Five- Year Results of a Prospective and Randomized Study: Experience with Combined Radiotherapy and mprove the survival rates of patients with potentially curable rectal carcinoma. However, no clear-cut data have yet been presented in this field of clinical investigation, especially with respect to whether pre- or postoperative radiation should be applied and which kind of fractionation or dosage

Intractable

The True Role of External-Beam Irradiation in the Initial Treatment of Cancer of the Rectum which includes 318 cases, is one of the first to demonstrate decisively a significant gain in the 5-year survival rate — 70% vs 60%. For the radiation oncologists the trials are invaluable to show that irradiation is capable of improving the prognosis of cancer of the rectum after surgery. However,

Heart-Rate

指耕作

0080-0015 als of Heidelberg and Zurich - must be given the mer­ it of achieving these goals. It was especially appropriate for the Department of Surgery in Heidelberg, in978-3-642-83295-6978-3-642-83293-2Series ISSN 0080-0015 Series E-ISSN 2197-6767

Anterior

乐器演奏者

fulcrum